Covestor »

Entrada Therapeutics shares owned by Covestor

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Covestor from 13F filings

Historical chart of Covestor investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Covestor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Covestor

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0k 221 4.52
2025-06-30 $3.0k 377 7.96
2025-03-31 $2.0k 198 10.10

More positions owned by Covestor

Vanguard Total Stock Mkt Etf Etf (VTI)
Vanguard Ftse Developed Etf Etf (VEA)
Vanguard Ftse Emerging Marke Etf (VWO)
Microsoft Corp Common (MSFT)
Vanguard High Dvd Yield Etf Etf (VYM)
Alphabet Inc-cl A Common (GOOGL)
Meta Platforms Inc-class A Class A (META)
St Joe Co/the Common (JOE)
Direxion Dly S&p 500 Bull 3x Etf (SPXL)
Terawulf Common (WULF)
Echostar Corp-a Common (SATS)
Amazon.com Common (AMZN)
Oshkosh Corp Common (OSK)
Kyndryl Holdings Common (KD)
Nebius Group Nv Common (NBIS)

View all positions for Covestor

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
BlackRock
Vanguard Group
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
Renaissance Technologies
TCG Crossover Management
State Street Corporation
Dimensional Fund Advisors
Royce & Associates
Citadel Advisors

View all funds holding Entrada Therapeutics